Affiliation: Medical College of Wisconsin
- Pharmacological management of acute agitationJohn Battaglia
Department of Psychiatry and Behavioural Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
Drugs 65:1207-22. 2005..These intramuscular atypical antipsychotics may represent a historical advance in the treatment of acute agitation...
- Calming versus sedative effects of intramuscular olanzapine in agitated patientsJohn Battaglia
University of Wisconsin Medical School, Madison, WI, USA
Am J Emerg Med 21:192-8. 2003....
- Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatmentPadraig Wright
Clinical Neuroscience, Lilly Research Centre, Eli Lilly and Company, Surrey, UK
Can J Psychiatry 48:716-21. 2003..To determine the antipsychotic efficacy and extrapyramidal safety of intramuscular (i.m.) olanzapine and i.m. haloperidol during the first 24 hours of treatment of acute schizophrenia...
- Best clinical practice with ziprasidone IM: update after 2 years of experienceDan L Zimbroff
Pacific Clinical Research Medical Group, Upland, California 91786, USA
CNS Spectr 10:1-15. 2005..Additional trials of ziprasidone IM in agitated patients in a variety of clinical setting are warranted to generate comparative risk/benefit data with conventional agents and other second-generation antipsychotics...
- A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophreniaJohn Battaglia
Program of Assertive Community Treatment, Madison, WI 53703, USA
Clin Ther 27:1612-8. 2005..Acutely agitated patients with schizophrenia might require treatment with IM antipsychotics, followed by a transition to oral medication...